Børsens News Service in English
ALK-Abelló revised expectations upwards
23-08-2010
09:37
ALK-Abelló upgrades its expectations for an organic growth of the allergy vaccine sales to 9-12 per cent from previously 5-8 per cent. The operating profit EBIT is now expected to be 10-15 per cent higher than in 2009 against the previous expectation of an EBIT slightly better than in 2009, when the operating profit amounted to DKK 175 million. In actual figures, ALK thus expects an operating profit of DKK 192.5-201.3 million. According to SME Direkt the analysts expect an EBIT of DKK 192 million for 2010. Alk maintains its expectation that the gross profit ratio will be marginally lower in 2010 than last year. Direkt/BNS
*****||*****ALK-Abelló revised expectations upwards*****||*****ALK-Abelló upgrades its expectations for an organic growth of the allergy vaccine sales to 9-12 per cent from previously 5-8 per cent. The operating profit EBIT is now expected to be 10-15 per cent higher than in 2009 against the previous expectation of an EBIT slightly better than in 2009, when the operating profit amounted to DKK 175 million. In actual figures, ALK thus expects an operating profit of DKK 192.5-201.3 million. According to SME Direkt the analysts expect an EBIT of DKK 192 million for 2010. Alk maintains its expectation that the gross profit ratio will be marginally lower in 2010 than last year. Direkt/BNS*****||*****
News from borsen.dk
